We are pleased to announce the addition of a new condition: Anxiety – Post-Traumatic Stress Disorder to our TreatGx medication decision support software. The PTSD treatment algorithm can be accessed by all TreatGx users. PTSD is a type of anxiety disorder…
TreatGx users now have access to the updated Chronic Pain – Low Back Pain treatment algorithm. A key feature of this update is being able to view all medication options at-a-glance. In addition to displaying personalized dosing options based on kidney function, liver function, drug-drug interactions, medical history, and pharmacogenetics (whether available or not), and continuing to provide guidance on gastroprotection…
We are pleased to announce the addition of a new condition to our TreatGx website! Ulcerative colitis is now available for access to all TreatGx users. Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) that can affect people of all ages. The disease can have…
With the industry moving towards personalized prescribing, pharmacists have become the key to successful pharmacogenomics (PGx) implementation. In this episode of the Precision Insights Podcast, Adrijana Kekic, PGx pharmacist and the program director of education, outpatient pharmacy at the Mayo Clinic, delves into the ways in which pharmacists are getting involved in PGx and the role they will play in the future of personalized medicine.
All TreatGx users now have access to the updated Chronic Pain – Neuropathic Pain treatment algorithm. Finding the optimal therapy to meet goals for chronic pain management can be challenging. This major update not only brings together information from multiple sources…
Introducing pharmacogenetics to a group of people, a population, can be tricky, but maintaining focus on patient experience, outcomes, and wellbeing can help. In this episode of Precision Insights, Curt Dame, VP of Health Solutions at Aon, explains his experience with implementing pharmacogenetics (PGx) into health plans.
We are pleased to announce the addition of two new conditions to our TreatGx medication decision support system. Alzheimer’s Disease and Insomnia can now be accessed by all TreatGx users. The Alzheimer’s algorithm provides treatment options for adults with mild, moderate, or severe Alzheimer’s disease, and includes guidance on medication titration and switching. Treatment options and dosing are…
The GenXys algorithm for Smoking Cessation has been updated and the new version is available to all TreatGx users. To continue to provide effective medication options and strategies for smoking cessation, we reviewed and incorporated information from recent guidelines and papers. These include the 2018 NICE guideline [1] and the 2018 American College of Cardiology expert consensus decision pathway [2]. We also included evidence from a recent Cochrane review on the use…
Some governing bodies have temporarily changed certain regulations so that healthcare providers can do as much as possible to deliver high-quality care virtually. Some areas of care become more challenging in a virtual environment, but with the right support tools in place, these challenges can be mitigated. In this blog, you’ll learn how these changes affect how online doctors can prescribe controlled substances.
All TreatGx users now have access to the updated Epilepsy and Rheumatoid Arthritis treatment algorithms. The Epilepsy update includes comprehensive treatment recommendations for specific types of epilepsy from the latest international guidelines, including the National Institute for Health and Care Excellence…
